Vivesto AB (VIVE)

0.72
0.00(-0.56%)
  • Volume:
    700,780
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    0.71 - 0.74

VIVE Overview

Prev. Close
0.72
Day's Range
0.71-0.74
Revenue
26.16M
Open
0.72
52 wk Range
0.57-3.03
EPS
-0.21
Volume
700,780
Market Cap
387.39M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
3,172,281
P/E Ratio
-4.47
Beta
0.578
1-Year Change
-68.2%
Shares Outstanding
538,043,455
Next Earnings Date
16 Nov 2022
What is your sentiment on Vivesto AB?
or
Vote to see community's results!

Vivesto AB Company Profile

Vivesto AB Company Profile

Employees
22
Market
Sweden
  • Type:Equity
  • Market:Sweden
  • ISIN:SE0000722365
  • S/N:538043455

Vivesto AB, formerly Oasmia Pharmaceutical AB is a Swecen-based pharma company that develops new treatment options for patients suffering from difficult-to-treat cancer. The company has a growing portfolio of projects in the clinical phase focused on advanced cancer. Apealea (paclitaxel micellar) is being developed for patients with ovarian cancer through a partnership with Elevar Therapeutics, Inc. Other development programs include Cantrixil, a clinical program in advanced ovarian cancer, and docetaxel micellar, which is being developed for widespread prostate cancer. Vivesto's patented technology platform is developed to improve the water solubility, efficacy and safety of drugs.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyBuyStrong SellSell
Technical IndicatorsBuyBuySellStrong SellStrong Sell
SummaryStrong BuyStrong BuyNeutralStrong SellStrong Sell